SG
TXG icon

Stonnington Group’s 10x Genomics TXG Stock Holding History

Stonnington Group’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		$244K Buy
+4,450
New +$208K 0.06% 210
2022
Q2 		– Sell
-10,000
Closed -$726K – 251
2022
Q1 		$726K Buy
+10,000
New +$875K 0.17% 119
2021
Q3 		– Sell
-3,630
Closed -$683K – 292
2021
Q2 		$683K Buy
+3,630
New +$657K 0.15% 142

Other funds holding TXG

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
SIM
SRS Investment Management New York $9.47B AUM 60.12% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $11.2B AUM 0.58% 1-Year Est. Return

Stonnington Group's TXG Position: Q1 2023 in Review

Stonnington Group opened a new position in 10x Genomics (TXG) in Q1 2023: 4,450 shares worth $244K. The stake represents 0.06% of the portfolio and ranks #210 among its holdings. This is a return to the name: Stonnington Group previously reported a position in TXG as recently as Q1 2022.

Stonnington Group first reported a position in TXG in Q2 2021 and has held it in 3 quarters since. The position peaked at $726K in Q1 2022. 258 funds tracked by Wall St. Rank hold TXG as of Q1 2023.

  • Stonnington Group held 4,450 shares of 10x Genomics worth $244K as of Q1 2023.
  • 10x Genomics was a new Stonnington Group position in Q1 2023.
  • 10x Genomics made up 0.06% of Stonnington Group's portfolio in Q1 2023, its #210 holding.
  • Stonnington Group first reported a position in 10x Genomics in Q2 2021 and has held it in 3 quarters since.
  • Stonnington Group's 10x Genomics position peaked at $726K in Q1 2022.
  • 258 funds tracked by Wall St. Rank held 10x Genomics as of Q1 2023.

Based on Stonnington Group's 13F filing for Q1 2023, filed 14 Apr 2023.